| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/28/2001 | EP1156814A2 Novel pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain |
| 11/28/2001 | EP1156808A2 Enhancement of return to independent living status with a growth hormone secretagogue |
| 11/28/2001 | EP1156806A1 Pharmaceutical composition containing proton pump inhibitors |
| 11/28/2001 | EP1156805A2 Use of polycyclic thiazole systems for producing medicaments for preventing or treating obesity |
| 11/28/2001 | EP1156804A1 Thrombopoietin mimetics |
| 11/28/2001 | EP1156803A1 LACTAM INHIBITORS OF FXa AND METHOD |
| 11/28/2001 | EP1156802A1 Pharmaceutic, dietetic and cosmetic compositions based on thioctic acid and cysteine |
| 11/28/2001 | EP1156801A1 Compounds and methods |
| 11/28/2001 | EP1156800A1 Method for treating exercise induced asthma |
| 11/28/2001 | EP1156799A1 Method for treating copd |
| 11/28/2001 | EP1156798A1 Felbamate derived compounds |
| 11/28/2001 | EP1156797A2 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
| 11/28/2001 | EP1156796A1 Antithrombotic use of glycine betaine |
| 11/28/2001 | EP1156795A1 Use of succinic acid or salts thereof and method of treating insulin resistance |
| 11/28/2001 | EP1156794A1 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using r(-)-ketoprofen |
| 11/28/2001 | EP1156793A2 Oral drug delivery system |
| 11/28/2001 | EP1156792A1 Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists |
| 11/28/2001 | EP1156791A1 Bupropion to treat viral diseases |
| 11/28/2001 | EP1156790A1 Combinations of formoterol and mometasone furoate for asthma |
| 11/28/2001 | EP1156789A1 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 11/28/2001 | EP1156787A1 Oxadiazole compounds and compositions for delivering active agents |
| 11/28/2001 | EP1156782A1 Echinocandin pharmaceutical formulations containing micelle-forming surfactants |
| 11/28/2001 | EP1156775A1 Reduction of hair growth |
| 11/28/2001 | EP1156770A1 Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof |
| 11/28/2001 | EP1156765A1 Hemostatic polymer useful for rapid blood coagulation and hemostasis |
| 11/28/2001 | EP1073412B1 Skin care agents containing combinations of active agents consisting of vitamin a derivatives and ubi- or plastoquinones |
| 11/28/2001 | EP0994878B1 Quinolone carboxylic acid derivatives |
| 11/28/2001 | EP0991407B1 Stabilization of acid sensitive benzimidazols with amino/cyclodextrin combinations |
| 11/28/2001 | EP0983068B1 THE USE OF 1,2,4-TRIAZOLO 1,5-c]PYRIMIDINE HETEROCYCLIC ANALOGUES FOR THE PREPARATION OF MEDICAMENTS USEFUL FOR THE TREATMENT OF CEREBROVASCULAR DISTURBANCES |
| 11/28/2001 | EP0918760B1 Biologically active benzothiazolone ethanamines |
| 11/28/2001 | EP0917588B1 Method for preparing a polydispersed saccharide composition and resulting polydispersed saccharide composition |
| 11/28/2001 | EP0914129B1 Use of aspirochlorine or derivatives thereof as immunosuppressive agents |
| 11/28/2001 | EP0906332B1 7alpha-(5-methylaminopentyl)-estratrienes, process for the preparation thereof, pharmaceutical preparations which contain said 7alpha-(5-methylaminopentyl)-estratrienes and use thereof for production of drugs |
| 11/28/2001 | EP0906268B1 Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors |
| 11/28/2001 | EP0880350B1 Multiple sclerosis treatment |
| 11/28/2001 | EP0850234B1 Novel heterocyclic compounds for the treatment of pain and use thereof |
| 11/28/2001 | EP0837845B1 Herpes ribonucleotide reductase inhibitors |
| 11/28/2001 | EP0830344B1 2-substituted benzimidazole derivatives as smooth muscle cell proliferation inhibitors |
| 11/28/2001 | EP0821963B1 Anticancer substance suppressing cancerous metastasis |
| 11/28/2001 | EP0817622B1 Medicament with angiotensin converting enzyme (ace) inhibitors suitable for transdermal application |
| 11/28/2001 | EP0787726B1 Novel compound, process for producing the same, and antitumor agent |
| 11/28/2001 | EP0784054B1 1,2,3,4-tetrahydroquinoxalinedione derivatives and use as glutamate receptor antagonists |
| 11/28/2001 | EP0783503B1 2,7-substituted octahydro-1h-pyrido[ 1,2-a]pyrazine derivatives |
| 11/28/2001 | EP0773783B1 Preparation of fusidic acid tablets |
| 11/28/2001 | EP0770068B1 Conformationally rigid bicyclic and adamantane derivatives useful as alpha 2-adrenergic blocking agents |
| 11/28/2001 | EP0758244B1 Controlled-release dosage forms of azithromycin |
| 11/28/2001 | EP0698108B1 Adenoviral vectors of animal origin and use thereof in gene therapy |
| 11/28/2001 | EP0695303B1 Pyridinium salts and their use for controlling helicobacter bacteria |
| 11/28/2001 | EP0690712B1 Taxanes having a pyridyl substituted side-chain |
| 11/28/2001 | EP0684819B1 Liquid pharmaceutical compositions based on ibuprofen |
| 11/28/2001 | EP0678027B1 Anti-atherosclerotic agents |
| 11/28/2001 | EP0677051B1 Derivatives of benzoylecgonine, ecgonine and ecgonidine as medicines |
| 11/28/2001 | EP0673368B1 Novel nicotinic acid esters |
| 11/28/2001 | EP0660716B1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| 11/28/2001 | EP0633773B1 Use of retinoic acid for the preparation of a medicament for the treatment of hyperpigmentation in black skin and method of lightening black skin with retinoic acid |
| 11/28/2001 | EP0512076B1 Method of treating cancer using structured lipids |
| 11/28/2001 | CN1324403A PRV-1 gene and the use thereof |
| 11/28/2001 | CN1324380A Gel composition |
| 11/28/2001 | CN1324374A Biodegradable low molecular weight triblock polyester polyethylene glocol copolymers having reverse thermal gelation properties |
| 11/28/2001 | CN1324364A Phosphoglycolipid and methods for its use |
| 11/28/2001 | CN1324363A Calcium (3S) tetrahydro-3-furanyl (1S, 2R)-3-[[(4-aminophenyl)sulfonyl] (isobutyl) amino]-1-benzyl-2-(phosphonooxy) propylcarbamate |
| 11/28/2001 | CN1324360A Bicyclic nitrogen heterocycles |
| 11/28/2001 | CN1324359A Tricyclic carboxamides |
| 11/28/2001 | CN1324358A Imidazo [4,5-C-] pyridine-4-one derivatives with factor XA inhibiting effect |
| 11/28/2001 | CN1324354A Vitreous form of know bradykinin antagonist |
| 11/28/2001 | CN1324353A Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 11/28/2001 | CN1324352A 2-phenylpyran-4-one derivatives |
| 11/28/2001 | CN1324351A Method for the preparation of citalopram |
| 11/28/2001 | CN1324350A Benzoylpyridazines |
| 11/28/2001 | CN1324349A Pyrazine compounds |
| 11/28/2001 | CN1324348A TAN-1057 derivatives |
| 11/28/2001 | CN1324347A Arylpiperzines as metalloproteinase inhibiting agents (MMP) and their use |
| 11/28/2001 | CN1324346A Method for producing (+)-exo-6-phenyl-3-azabicyclo-[3.2.O] heptanes |
| 11/28/2001 | CN1324344A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 11/28/2001 | CN1324258A Aglyco products and method of use |
| 11/28/2001 | CN1324251A Method of stimulating prosaposin receptor activity |
| 11/28/2001 | CN1324250A Method for treating or preventing viral infections and associated diseases |
| 11/28/2001 | CN1324248A Drugs for relieving carbonyl stress and peritoneal dialysates |
| 11/28/2001 | CN1324246A Method for enhancing wound healing |
| 11/28/2001 | CN1324245A Activation and protection of T-cells (CD4+ and CD8+) using and H2 receptor agonist and other T-cell activating agents |
| 11/28/2001 | CN1324240A Treatment of disorders of the outer retina |
| 11/28/2001 | CN1324239A Analgesics |
| 11/28/2001 | CN1324238A Amelioration of apomorphine adverse effects |
| 11/28/2001 | CN1324237A Method for improving pharmacokinetics of tipranavir |
| 11/28/2001 | CN1324236A Delta 9 tetrahydrocannabinol (delta 9 THC) solution metered dose inhalers and methods of use |
| 11/28/2001 | CN1324235A Compositions of and process for producing isotretinoin having low particle size |
| 11/28/2001 | CN1324234A Fructosamine oxidase: antagonists and inhibitors |
| 11/28/2001 | CN1324233A Controlled-release pharmaceutical formulations contg. a CGMP PDE-5 inhibitor |
| 11/28/2001 | CN1324212A Method for treating or preventing viral infections and associated diseases |
| 11/28/2001 | CN1323797A Chinese chestnut flower flavone compound and its extraction process |
| 11/28/2001 | CN1323796A Novel cyclobutaneindazol carboxylamine compound, their prepn. method and pharmaceutical compositions |
| 11/28/2001 | CN1323794A Novel hetero naphthenic benzcyclobutane and heterocyclo acryl benzcyclobutane compound, their prepn. method and pharmaceutical composites |
| 11/28/2001 | CN1323793A Schizonepeta lactone and its extraction process and use |
| 11/28/2001 | CN1323607A Fast-acting heart disease curing drop pill |
| 11/28/2001 | CN1323602A Piles treating medicine and its prepn. |
| 11/28/2001 | CN1323596A Toxin-absorbing drying medicine |
| 11/28/2001 | CN1323588A New use of ginseng and ginseng stalk and leaf extractive in preventing and treating osteoposis |
| 11/28/2001 | CN1323583A Medicinal use of beta-ecdysterone |
| 11/28/2001 | CN1323582A Prepn. of injecta powder containing tannic acid component |
| 11/28/2001 | CN1323581A Calcium making-up agent material |